Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Eoganachton Feb 29, 2024 11:11am
249 Views
Post# 35906548

Dr. McFarland Named to National Academy of Inventors

Dr. McFarland Named to National Academy of InventorsUTA FACULTY NAMED NATIONAL ACADEMY OF INVENTORS SENIOR MEMBERS

McFarland and Varanasi recognized for innovative work, dedication to students
 
WEDNESDAY, FEB 28, 2024 • NEPH RIVERA : CONTACT

Photo of UTA faculty member Sherri McFarland" _languageinserted="true

The National Academy of Inventors (NAI) has named two University of Texas at Arlington faculty members as senior members for their innovative work producing technologies that aspire to have real impact on the welfare of society.
 
Sherri McFarland, professor of chemistry and biochemistry, and Venu Varanasi, associate professor of graduate nursing, are UTA’s newest NAI senior members. According to the NAI, senior members are “rising stars who foster a spirit of innovation within their communities and institutions while educating and mentoring the next generation of inventors.”
 
McFarland thanked the University and its NAI chapter for nominating her.
 
“It is quite an honor to be recognized by those who have already made important contributions to society through their own inventions,” McFarland said. “I would like to acknowledge the excellent researchers, students, colleagues and collaborators I’ve had over the years who have made this possible.”
 
Dereje Agonafer, presidential distinguished professor of mechanical and aerospace engineering at UTA and past president of the University’s NAI chapter, nominated McFarland. He noted the dozens of papers she has published, as well as her entrepreneurial spirit in founding her company, Photodynamic Inc., and the drug she developed that is in human clinical trials for treating cancer.
 
“Professor McFarland’s contributions to scientific research are evident with patents that have almost all been licensed,” Agonafer said. “In addition, her dedication to the mentorship of students has been outstanding. Congratulations to her on this well-deserved recognition.”
 
Photo of UTA faculty member Venu Varanasi" _languageinserted="true

Varanasi was lauded for his cutting-edge research focusing on biomaterials and regenerative medicine.
 
“Becoming a senior member of the National Academy of Inventors is a tremendous honor,” he said. “It reflects all the hard work and dedication from my mentees and mentors throughout my career. I share this award with all of my research teammates and thank UTA for its continued support of these efforts.”
 
He was recently awarded a five-year, multi-million-dollar National Institutes of Health grant to continue those efforts, and a number of his inventions and commercialization opportunities now being evaluated for potential therapeutic intervention for bone fractures and defects in clinical use.
 
“Dr. Varanasi’s recognition as a senior member is a testament to his contributions to scientific research and biomedical applications through breakthrough technologies, publications, and patents and, more than anything else, to his outstanding dedication to the mentorship of students,” said Gabriela Wilson, co-director of UTA’s Multi-Interprofessional Center for Health Informatics and current UTA NAI chapter president. “He is an outstanding colleague, and I cannot think of a better person deserving this honor.”
 
McFarland and Varanasi join an exclusive group of just over 400 members who hold over 5,800 U.S. patents. They will be officially inducted as members during the NAI’s upcoming annual conference this June in Raleigh, North Carolina.
<< Previous
Bullboard Posts
Next >>